Etiopathogenesis of Gastric Cancer

  • Goral, Vedat (Department of Gastroenterology, Medical Faculty, Izmir University)
  • Published : 2016.06.01

Abstract

Gastric cancer is a multifactorial and complex malignant disease seen commonly worldwide. It is one of the few malignant conditions in which the etiology involves infectious agents (Helicobacter pylori), but there are many other risk factors incuding high salt intake. Its pathogenesis generally involves interactions between environmental factors and genetic disposition. It is currently onsidered that stem cells may play a central role in gastric cancer development.

Keywords

Gastric cancer;Helicobacter pylori;oncogenes;stem cells

References

  1. Compare D, Rocco A, Nardone G (2010). Risk factors in gastric cancer. Eur Rev Med Pharmacol Sci, 14, 302-8.
  2. Chung HW, Lim JB (2014). Role of the tumor microenvironment in the pathogenesis of gastric carcinoma. World J Gastroenterol, 21, 1667-80.
  3. Ding SZ, Zheng PY (2012). Helicobacter pylori infection induced gastric cancer; advance in gastric stem cell research and the remaining challenges. Gut Pathog, 8,1-11.
  4. Ding SZ, Goldberg JB, Hatakeyama H (2010). Helicobacter pylori infection, oncogenic pathways and epigenetic mechanisms in gastric carcinogenesis. Future Oncol, 6, 851-862. https://doi.org/10.2217/fon.10.37
  5. Fuccio L, Eusebi LH, Bazzoli F (2010). Gastric cancer, Helicobacter pylori infection and other risk Factors. World J Gastrointest Oncol, 15, 342-347.
  6. Gomceli I, Demiriz B, Tez M (2012). Gastric carcinogenesis. World J Gastroenterol, 7, 5164-70.
  7. Grabsch HI, Tan P (2013). Gastric cancer pathology and underlying molecular mechanisms. Dig Surg, 30, 150-8. https://doi.org/10.1159/000350876
  8. Han TS, Hur K, Xu G, et al (2015). MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1. Gut, 64, 203-214. https://doi.org/10.1136/gutjnl-2013-306640
  9. Hu B, El Hajj N, Sittler S, et al (2012). Gastric cancer: Classification, histology and application of molecular pathology. J Gastrointest Oncol, 3, 251-61.
  10. Jiang HB, Yang TJ, Lu P, et al (2014). Ma YJ. Gene expression profiling of gastric cancer. Eur Rev Med Pharmacol Sci, 18, 2109-15.
  11. Jiang HB, Yang TJ, Lu P, et al (2014). Gene expression profiling of gastric cancer. Eur Rev Med Pharmacol Sci, 18, 2109-15.
  12. Iizasa H, Nanbo A, Nishikawa J, et al (2012). H. Epstein-Barr Virus (EBV)-associated gastric carcinoma. Viruses, 4, 3420-39. https://doi.org/10.3390/v4123420
  13. McLean MH, El-Omar EM (2014). Genetic of gastric cancer. Nat Rev Gastroenterol Hepatol, 11, 664-74. https://doi.org/10.1038/nrgastro.2014.143
  14. Nadalud LD, Ford JM (2013). Molecular profiling of gastric cancer: toward personalized cancer medicine. J Clin Oncol, 1, 838-9.
  15. Nagini S (2012). Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol, 15, 156-69.
  16. Wang F, Sun GP, Zou YF, et al (2012). MicroRNAs as promising biomarkers for gastric cancer. Cancer Biomark, 11, 259-67. https://doi.org/10.3233/CBM-2012-00284
  17. Zabaleta J (2012). MicroRNA: A Bridge from H. pylori Infection to gastritis and gastric cancer development. Front Genet, 14, 3-294.